Purple Biotech Ltd (PPBT) Company Annual Revenue
Purple Biotech management is focusing on developing methods to combat tumor resistance, which is confirmed by the company's trading revenue trend on the GURU.Markets chart, where 0.00 serves as the base parameter value. The development of the CM24 antibody creates a closed patent perimeter, while intensive trials of CM24 and NT219 drugs for solid tumors ensure high scientific productivity.
Analytical breakdowns for Purple Biotech
- market price and analyst price targets:
- market capitalization details:
- business book valuation details:
- debt obligations and liquidity statistics:
Aggregate Debt to Equity Purple Biotech|PPBT - Long-Term Debt to Equity|Short-Term Debt to Equity Purple Biotech Ltd|PPBT - Company Aggregate Debts|Debts to Book Value Purple Biotech Ltd.|PPBT - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Purple Biotech|Quick Liquidity purple-biotech.com
- net income and valuation ratios data:
PPBT - Net Profit|Company Profit Forecast Purple Biotech|PPBT - Price to Earnings Ratio|Projected Price to Earnings Ratio purple-biotech.com|PPBT - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Purple Biotech Ltd.|PPBT - Operating profit EBITDA|Net earnings per one share for the last twelve months Purple Biotech|PPBT - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months purple-biotech.com|PPBT - Earnings growth in current year|Expected earnings per share trend next year Purple Biotech
- sales volume and revenue indicators:
Summary company analysis:PPBT (Kitov Pharma)
Purple Biotech operates as a fabless biotech, fully outsourcing antibody production and clinical trials to external contractors. The company's sales statistics record actual cash inflows from realizations, allowing investors to filter out speculative noise and assess real demand for drugs, where any sharp impulse in the curve serves as an indicator of either fundamental growth or market overheating.
Competing companies
Company Total Revenue BeiGene Oncology ONC|Company Revenue Halozyme Therapeutics (HALO)|RVMD: Company Annual Revenue|Ascentage Pharma - Company Sales|Revenue and Sales Volume CG Oncology Inc CGON|URGN - Company Revenue|Company Sales Revenue BCAX (Bicara Corp)|Personalis, Inc. (PSNL) - Company Revenue|Company Annual Revenue ERAS (erasca.com)|Company Revenue Delcath Systems|Company Revenue YMAB|Revenue and Sales Volume AURA|CADL - Company Total Revenue|Accuray Incorporated - Company Sales|Company Sales Revenue SLS|Actuate Therapeutics - Revenue and Sales Volume|CTOR: Company Revenue|HURA: Revenue and Sales Volume|TARA - Company Gross Revenue|Company Revenue Fate Therapeutics, Inc.|Company Total Revenue Aadi Bio WHWK|Company Sales TCRX (TScan Therapeutics)|Company Total Sales CSBR|Revenue and Sales Volume XBIT (XBiotech)|CEL-SCI Corp. (CVM) - Company Total Revenue|OS Therapies Incorporated - Revenue and Sales Volume|Radiopharm Theranostics Ltd (RADX) - Company Sales|ARTV: Revenue and Sales Volume|Adlai Nortye - Company Sales Revenue|Company Revenue Veru Pharma|Tempest Therapeutics Corp - Company Annual Revenue|Company Revenue Xilio Therapeutics, Inc. (XLO)|RENB: Company Annual Revenue|Revenue and Sales Volume MURA (Mural Oncology)|Kairos Pharma Limited - Company Revenue|OKUR: Company Sales|CytoMed Therapeutics - Company Total Sales|CRIS: Revenue and Sales Volume|Company Sales Apollomics|THAR (Tharimmune) - Revenue and Sales Volume|Revenue and Sales Volume Advanced Biomed Corp|Company Revenue Genprex, Inc (GNPX)|calidibio.com - Company Sales Volume|Revenue and Sales Volume SBFM (Sunshine Biopharma)|XBIO - Company Sales|Salarius Pharmaceuticals, Inc. - Revenue and Sales Volume|Company Total Revenue American Oncology Network|BeOne Medicines (BGNE) - Company Revenue|Checkpoint Therapeutics Inc - Company Sales Revenue|Company Sales ELEV|ICAD: Company Sales Revenue|Revenue and Sales Volume IKNA|Company Sales Notable Labs Ltd NTBL|Viracta Therapeutics, Inc. - Company Sales|Revenue and Sales Volume MorphoSys Corporation MOR|NAYA - Company Revenue|Company Sales Revenue AAPGV (ascentage.com)
